Specific Biologics Announces Oversubscribed US$35 Million Series A Financing to Advance Gene-Editing Therapy for ALS

02 Nov 2026

View Full Article

Latest

Specific Biologics Announces Oversubscribed US$35 Million Series A Financing to Advance Gene-Editing Therapy for ALS

02 November 2026

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

All Articles

November 2, 2026

Specific Biologics Announces Oversubscribed US$35 Million Series A Financing to Advance Gene-Editing Therapy for ALS

October 13, 2026

Genesys Capital Announces Second Close of Genesys University Seed Fund, Welcoming Sunnybrook and UHN as Hospital Partners

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026